A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

<p>Abstract</p> <p>Background</p> <p>Platinum-based combinations are the standard second-line treatment for platinum-sensitive ovarian cancer (OC). This randomized phase II study was undertaken in order to compare the combination of carboplatin and pegylated liposomal d...

Full description

Bibliographic Details
Main Authors: Briasoulis Evangelos, Samantas Epaminondas, Makatsoris Thomas, Timotheadou Eleni, Kosmidis Paris, Kalofonos Haralabos P, Fountzilas George, Bamias Aristotelis, Papadimitriou Christos, Aravantinos Gerasimos, Linardou Helena, Bafaloukos Dimitrios, Christodoulou Christos, Papakostas Pavlos, Pectasides Dimitrios, Dimopoulos Athanasios M
Format: Article
Language:English
Published: BMC 2010-01-01
Series:BMC Medicine
Online Access:http://www.biomedcentral.com/1741-7015/8/3

Internet

http://www.biomedcentral.com/1741-7015/8/3

Similar Items